CDXFF logo

Cloud DX Inc. (CDXFF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cloud DX Inc. (CDXFF), Healthcare sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 54/100 puan alıyor.

Son analiz: 18 Mar 2026
54/100 AI Puanı

Cloud DX Inc. (CDXFF) Sağlık ve Boru Hattı Genel Bakışı

CEORobert Manson Kaul
MerkezKitchener, US
Halka Arz Yılı2021
SektörHealthcare

Cloud DX Inc. provides a remote patient monitoring platform, enabling virtual healthcare for chronic illnesses and post-operative recovery. Their connected health kits and VITALITI monitor offer comprehensive data collection, serving hospitals, academic institutions, and health authorities in both Canada and the United States.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 18 Mar 2026

Yatırım Tezi

Cloud DX Inc. presents a notable research candidate within the expanding telehealth market. The company's comprehensive remote patient monitoring platform addresses the growing need for virtual healthcare solutions, particularly for chronic disease management and post-operative care. Key value drivers include increasing adoption of telehealth services, strategic partnerships with healthcare providers, and expansion into new geographic markets. The company's negative profit margin of -571.0% and negative gross margin of -247.9% indicate significant challenges in achieving profitability. Upcoming catalysts include potential contract wins with large hospital networks and expansion of the VITALITI product line. Investors should monitor the company's ability to improve its financial performance and secure sustainable revenue streams.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $0.01B reflects its small size and growth potential within the telehealth market.
  • P/E ratio of -1.13 indicates the company is currently not profitable.
  • Profit Margin of -571.0% highlights significant challenges in achieving profitability.
  • Gross Margin of -247.9% suggests high costs associated with its services.
  • Beta of 0.44 indicates lower volatility compared to the overall market.

Rakipler & Benzerleri

Güçlü Yönler

  • Comprehensive remote patient monitoring platform.
  • Connected Health Kits with various monitoring devices.
  • VITALITI vital sign monitor with advanced capabilities.
  • Established relationships with healthcare providers.

Zayıflıklar

  • Negative profit margin and gross margin.
  • Limited market share compared to larger competitors.
  • Reliance on third-party suppliers for some medical devices.
  • OTC market listing may limit investor access.

Katalizörler

  • Upcoming: Potential contract wins with large hospital networks in the US.
  • Upcoming: Expansion of the VITALITI product line with new features and capabilities.
  • Ongoing: Increasing adoption of telehealth and remote patient monitoring services.
  • Ongoing: Strategic partnerships with healthcare providers to expand market reach.

Riskler

  • Potential: Intense competition in the telehealth market.
  • Potential: Changes in government regulations and reimbursement policies.
  • Ongoing: Negative profit margin and gross margin.
  • Ongoing: Limited market share compared to larger competitors.
  • Ongoing: Reliance on third-party suppliers for some medical devices.

Büyüme Fırsatları

  • Expansion into the US Market: Cloud DX has the opportunity to further penetrate the US market, leveraging the increasing adoption of telehealth solutions and the growing demand for remote patient monitoring services. The US telehealth market is projected to reach $55.5 billion by 2026, providing a significant growth runway for Cloud DX. Success in this market hinges on securing partnerships with US-based healthcare providers and demonstrating the value of its platform in improving patient outcomes and reducing healthcare costs.
  • Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals, clinics, and other healthcare providers can significantly expand Cloud DX's reach and market penetration. These partnerships can provide access to a larger patient base and facilitate the integration of Cloud DX's platform into existing healthcare workflows. The company can leverage these partnerships to drive adoption of its connected health kits and VITALITI monitor, generating recurring revenue streams and establishing a strong foothold in the telehealth market.
  • Development of New Product Features and Services: Investing in the development of new product features and services can enhance the value proposition of Cloud DX's platform and attract new customers. This includes incorporating advanced analytics capabilities, integrating with other healthcare IT systems, and expanding the range of supported medical devices. By continuously innovating and adapting to the evolving needs of the market, Cloud DX can maintain a competitive edge and drive long-term growth.
  • Focus on Chronic Disease Management: Cloud DX can capitalize on the growing prevalence of chronic diseases by focusing its efforts on developing specialized solutions for managing conditions such as diabetes, heart disease, and respiratory illnesses. The chronic disease management market is estimated to reach $20 billion by 2028, presenting a significant opportunity for Cloud DX to establish itself as a leader in this space. This involves tailoring its platform to meet the specific needs of patients with chronic conditions and demonstrating the effectiveness of its solutions in improving patient outcomes and reducing healthcare costs.
  • Leveraging Government Incentives and Reimbursement Policies: Cloud DX can benefit from government incentives and reimbursement policies that support the adoption of telehealth and remote patient monitoring services. Many countries are implementing policies to encourage the use of telehealth, including providing reimbursement for remote patient monitoring services. By staying informed about these policies and actively engaging with government agencies, Cloud DX can position itself to take advantage of these opportunities and drive adoption of its platform.

Fırsatlar

  • Expansion into the US market.
  • Strategic partnerships with healthcare providers.
  • Development of new product features and services.
  • Focus on chronic disease management.

Tehditler

  • Intense competition in the telehealth market.
  • Changes in government regulations and reimbursement policies.
  • Technological advancements by competitors.
  • Economic downturn affecting healthcare spending.

Rekabet Avantajları

  • Proprietary Cloud DX Connected Health platform provides a comprehensive remote patient monitoring solution.
  • Established relationships with academic institutions, hospitals, and health authorities.
  • VITALITI vital sign monitor offers a unique and advanced monitoring capability.
  • Focus on chronic disease management provides a specialized market niche.

CDXFF Hakkında

Cloud DX Inc. is a remote patient monitoring company that provides an end-to-end virtual healthcare platform. Founded with the vision of transforming healthcare delivery through technology, the company focuses on enabling remote monitoring of patients with chronic illnesses such as chronic obstructive pulmonary disease (COPD) and congestive heart failure. Their platform also supports patients recovering from surgery and those managing COVID-19 outside of traditional hospital settings. Cloud DX's core offering is the Cloud DX Connected Health platform, which includes connected health kits featuring devices like Bluetooth pulse oximeters and wireless weight scales. These kits can be expanded with optional third-party devices such as Bluetooth blood pressure monitors, digital thermometers, and glucose meters. The company also offers VITALITI, a vital sign monitor capable of measuring electrocardiograph (ECG), heart rate, oxygen saturation, respiration rate, core body temperature, blood pressure, movement, steps, and posture. Cloud DX serves a diverse range of clients, including academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company's solutions aim to improve patient outcomes, reduce hospital readmissions, and enhance the efficiency of healthcare delivery. Headquartered in Kitchener, Canada, Cloud DX is committed to expanding its reach and impact in the rapidly evolving telehealth market.

Ne Yaparlar

  • Offers Cloud DX Connected Health, an end-to-end virtual healthcare platform.
  • Monitors patients with chronic illnesses like COPD and congestive heart failure remotely.
  • Supports patients recovering from surgery and COVID-19 patients outside hospitals.
  • Provides Cloud DX Connected Health Kits with Bluetooth pulse oximeters and wireless weight scales.
  • Offers VITALITI, a vital sign monitor for measuring ECG, heart rate, and other vital signs.
  • Serves academic institutions, hospitals, and health authorities in Canada and the US.

İş Modeli

  • Sells Cloud DX Connected Health Kits to healthcare providers and patients.
  • Generates revenue through subscription fees for access to the Cloud DX Connected Health platform.
  • Offers VITALITI vital sign monitors for continuous patient monitoring.
  • Partners with third-party suppliers for additional medical devices.

Sektör Bağlamı

Cloud DX Inc. operates within the rapidly growing telehealth and remote patient monitoring market. The industry is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in technology. The competitive landscape includes companies like ATBPF (Air T, Inc.), BNOEF (BioNxt Solutions Inc.), CNPOF (Care Net Population Health Management Inc.), CRBKF (Carebook Technologies Inc.), and DOCRF (CloudMD Software & Services Inc.), each offering various telehealth solutions. Cloud DX differentiates itself through its comprehensive platform and focus on chronic disease management.

Kilit Müşteriler

  • Academic institutions in Canada and the United States.
  • Large hospitals and healthcare systems.
  • Provincial health authorities in Canada.
  • Physician practices in the United States.
AI Güveni: 71% Güncellendi: 18 Mar 2026

Finansallar

Grafik & Bilgi

Cloud DX Inc. (CDXFF) hisse senedi fiyatı: Price data unavailable

Son Haberler

CDXFF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CDXFF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CDXFF için Wall Street fiyat hedefi analizi.

MoonshotScore

54/100

Bu puan ne anlama geliyor?

MoonshotScore, CDXFF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Robert Manson Kaul

CEO

Robert Manson Kaul serves as the CEO of Cloud DX Inc. His background includes extensive experience in the healthcare technology sector, with a focus on developing and commercializing innovative solutions. Prior to joining Cloud DX, he held leadership positions at various healthcare companies, where he was responsible for driving growth and expanding market reach. He has a strong track record of building successful teams and executing strategic initiatives.

Sicil: Under Robert Manson Kaul's leadership, Cloud DX Inc. has focused on expanding its remote patient monitoring platform and securing partnerships with healthcare providers. Key achievements include the development and launch of the VITALITI vital sign monitor and the expansion of the company's presence in the US market. He has also overseen the implementation of strategic initiatives aimed at improving patient outcomes and reducing healthcare costs.

CDXFF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Cloud DX Inc. may not meet the minimum financial or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for CDXFF shares on the OTC market is likely to be limited, potentially resulting in wider bid-ask spreads and difficulties in executing large trades without significantly impacting the price. The trading volume may be low, making it challenging to buy or sell shares quickly. Investors should be aware of these liquidity constraints and consider using limit orders to manage their trading costs and execution risks.
OTC Risk Faktörleri:
  • Limited financial disclosure and regulatory oversight.
  • Higher price volatility due to lower trading volume.
  • Potential for fraud or manipulation.
  • Difficulty in obtaining accurate and timely information.
  • Limited liquidity and wider bid-ask spreads.
Durum Tespiti Kontrol Listesi:
  • Verify the company's registration and legal standing.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their track record.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or investigations.
Meşruiyet Sinyalleri:
  • Established relationships with academic institutions and hospitals.
  • Proprietary Cloud DX Connected Health platform and VITALITI monitor.
  • Focus on chronic disease management.
  • Presence in both Canadian and US markets.

Yatırımcılar Cloud DX Inc. (CDXFF) Hakkında Ne Soruyor

CDXFF için değerlendirilmesi gereken temel faktörler nelerdir?

Cloud DX Inc. (CDXFF) şu anda yapay zeka skoru 54/100, orta puanı gösteriyor. Temel güçlü yan: Comprehensive remote patient monitoring platform.. İzlenmesi gereken birincil risk: Potential: Intense competition in the telehealth market.. Bu bir finansal tavsiye değildir.

CDXFF MoonshotScore'u nedir?

CDXFF şu anda MoonshotScore'da 54/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CDXFF verileri ne sıklıkla güncellenir?

CDXFF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CDXFF hakkında ne diyor?

CDXFF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CDXFF'a yatırım yapmanın riskleri nelerdir?

CDXFF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition in the telehealth market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CDXFF'ın P/E oranı nedir?

CDXFF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CDXFF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CDXFF aşırı değerli mi, yoksa düşük değerli mi?

Cloud DX Inc. (CDXFF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CDXFF'ın temettü verimi nedir?

Cloud DX Inc. (CDXFF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is based on the most recent available information.
  • OTC market data may be limited and less reliable than data for exchange-listed stocks.
  • AI analysis is pending and may provide additional insights in the future.
Veri Kaynakları

Popüler Hisseler